Clinical Trials Directory

Trials / Completed

CompletedNCT05803122

Validation of the I-UDS Neuropsychological Battery

Validation of the I-UDS Neuropsychological Battery in Patients With Mild Cognitive Impairment and Alzheimer's Disease

Status
Completed
Phase
Study type
Observational
Enrollment
252 (actual)
Sponsor
IRCCS National Neurological Institute "C. Mondino" Foundation · Academic / Other
Sex
All
Age
40 Years – 89 Years
Healthy volunteers

Summary

The current project entails the validation of the Italian version of the Uniform Data Set (I-UDS) neuropsychological in patients with neurodegenerative diseases, specifically in patients with Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD). Specifically, the final aim is to explore the ability of the battery to differentiate the cognitive profiles of the two groups of patients.

Detailed description

The harmonization of procedures for neuropsychological assessment in dementia disorders is essential for the development of shared activities and projects within the IRCCS Network of Neuroscience and Neurorehabilitation (RIN). To this end, a previous project of the network was dedicated to the translation and adaptation of the Uniform Data Set (UDS) neuropsychological battery, following the similar initiative of the National Alzheimer's Coordinating Center (NACC) USA . This project led to the creation of the I-UDS, which can be administered via a tablet application and consists of tests aimed at investigating different cognitive domains, namely memory, attention, language, executive and visuospatial skills. Normative data were obtained from a sample of 433 healthy participants. In order to be able to use the I-UDS battery in clinical and research settings, it is essential to validate its application in patients with neurodegenerative diseases. In particular, in line with the NACC initiative, the battery aims to trace and highlight the continuum between Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD). The present multicenter study therefore aims to test the I-UDS battery in patients with clinical diagnoses of MCI and AD, in order to explore its ability to differentiate the cognitive profiles of the two groups of patients.

Conditions

Interventions

TypeNameDescription
OTHERUniform Data Set (UDS) neuropsychological batteryUniform Data Set (UDS) neuropsychological battery was administered to patients with Mild Cognitive Impairment (MCI) and patients with Alzheimer's Disease

Timeline

Start date
2022-07-15
Primary completion
2022-12-30
Completion
2022-12-30
First posted
2023-04-07
Last updated
2023-04-07

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05803122. Inclusion in this directory is not an endorsement.

Validation of the I-UDS Neuropsychological Battery (NCT05803122) · Clinical Trials Directory